Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Progress in Medicinal Chemistry|May 5, 2020
Small molecules-Giant leaps for immuno-oncologyLisa Kötzner, Bayard Huck, Sakshi Garg, et al.Nature Reviews. Drug Discovery|August 18, 2022
The expanding role for small molecules in immuno-oncologyRienk Offringa, Lisa Kötzner, Bayard Huck, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2004
The identification and optimization of 2,4-diketobutyric acids as flap endonuclease 1 inhibitorsL Nathan Tumey, Bayard Huck, Elizabeth Gleason, et al.Bioorganic & Medicinal Chemistry Letters|December 18, 2004
The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitorsL Nathan Tumey, David Bom, Bayard Huck, et al.ACS Medicinal Chemistry Letters|May 17, 2023
Selective Wee1 Inhibitors Led to Antitumor Activity <i>In Vitro</i> and Correlated with MyelosuppressionSatenig Guler, Maria C DiPoto, Alejandro Crespo, et al.Molecular Cancer Therapeutics|August 20, 2024
Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In VivoKai Schiemann, Natalya Belousova, Armine Matevossian, et al.Bioorganic & Medicinal Chemistry Letters|April 11, 2013
SAR and evaluation of novel 5H-benzo[c][1,8]naphthyridin-6-one analogs as Aurora kinase inhibitorsSrinivasa Karra, Yufang Xiao, Xiaoling Chen, et al.Journal of Medicinal Chemistry|October 1, 2021
Identification of Clinical Candidate M2698, a Dual p70S6K and Akt Inhibitor, for Treatment of PAM Pathway-Altered CancersLizbeth DeSelm, Bayard Huck, Ruoxi Lan, et al.Bioorganic & Medicinal Chemistry|August 2, 2023
Discovery of quinazoline HPK1 inhibitors with high cellular potencyMomar Toure, Theresa Johnson, Bin Li, et al.Pageof 1